Groinss v trial
WebHome / GROINSS-V3. GROINSS-V3. Trial Description: Groningen International Study on Sentinel Nodes in Vulvar Cancer-III (GROINSS-VIII) Lead Cooperative Group: DGOG. Participating Groups: GOG. Trial Number: ClinicalTrials.gov Identifier: NCT05076942. Disease Site: Vulvar. Trial Status: WebSep 27, 2024 · GROINSS-V II; 2024 (2005 - 2016) PMID 34432481-- "Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II" (Oonk MHM, J Clin Oncol. 2024 Aug 25;JCO2100006. doi: 10.1200/JCO.21.00006) Prospective multicenter Phase …
Groinss v trial
Did you know?
WebFootnotes. Contributors MO is the global Principal Investigator of the GROINSS-V III clinical trial and the guarantor of this study. AVdZ is a Co-Investigator of the trial and the senior … WebJan 31, 2024 · GROINSS-V-II was a prospective multicenter phase II single-arm treatment trial, performed in patients with early-stage vulvar cancer (unifocal squamous cell cancer …
WebAug 31, 2024 · Groningen International Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) III: A Prospective Phase II Treatment Trial Principal Investigator. Brian … WebNov 10, 2024 · Methods: GROINSS-V-II was a prospective multicenter phase-II single-arm treatment trial, including patients with early-stage vulvar cancer (diameter < 4 cm) …
WebOct 13, 2024 · GROINSS-V III will investigate this regimen. Objective: The primary objective of this study is to investigate the safety of replacing inguinofemoral lymphadenectomy by … WebIn GROINSS-V sentinel-node detection was followed by inguinofemoral lymphadenectomy if metastatic disease was identified in the sentinel node, either by routine examination or pathological ultrastaging. Sentinel nodes were independently reviewed by two pathologists. Metastatic disease was identified in one or more sentinel nodes in 135 (33%) of ...
WebOct 1, 2024 · The sequel to the GROINSS-V trial, GROINSS-V II, is investigating the efficacy of increase in groin lymph node recurrence in cases with sentinel lymph node metastasis >2 mm or extranodal extension ...
WebThe sequel to the GROINSS-V trial, GROINSS-V II, is investigating the efficacy of increase in groin lymph node recurrence in cases with sentinel lymph node metastasis >2 mm or extranodal extension ... mean bulldog vectorWebDec 28, 2011 · Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection (GROINSS-V) The safety and scientific validity of this … pearson chi-square test of independenceWebHome / GROINSS-V3. GROINSS-V3. Trial Description: Groningen International Study on Sentinel Nodes in Vulvar Cancer-III (GROINSS-VIII) Lead Cooperative Group: DGOG. … mean bulls attacking peopleWebGROINSS-V III: A.4.1: Sponsor's protocol code number: 2016-00601: A.7: Trial is part of a Paediatric Investigation Plan: No : A.8: ... The trial involves single site in the Member State concerned No : E.8.4: The trial involves multiple sites in the Member State concerned : Yes : E.8.4.1: Number of sites anticipated in Member State concerned ... pearson chi2 testWebTimeline (first patient –trial closing): Dec 2005 –Oct 2016 Publications: Oonk M et al, Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010 Analysis: June-Sept 2024 mean bulls youtubeWebObjective: In 2008 GROINSS-V-I, the largest validation trial on the sentinel node (SN) procedure in vulvar cancer, showed that application of the SN-procedure in patients with … pearson chi-squared goodness of fit statisticWebWe are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi … mean brightness